Sunovion to Initiate Recruitment for Aptiom® (eslicarbazepine acetate) Clinical Study with Integrated Digital Health Technology to Aid Seizure Detection
Orthopedics remain at risk, but shares are priced below worst-case scenarios.
While we remain bullish on the sector, health-care growth depends on the economy.
A subscriber to StockInvestor recently asked me how exactly I plan on managing the Tortoise and Hare to continue to beat the market. I replied that I planned to continue focusing on companies with wide economic moats that will compound in value over time, and then only buy those companies if they ...